Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Funding for this research was provided by gifts from RAND supporters and income from the operation of RAND Survey Panels
Patients taking medications that affect heart rate, particularly beta-blockers, calcium channel blockers, or antiarrhythmic drugs, should be identified, as these may modify the heart rate response to GLP-1 therapy
prescribed semaglutide who did not have a diagnosis of type 2 diabetes rapidly increased from 11.4% in 2020 to 41.7% in 2023 [Figure 2]
In 2026, GLP-1 medications are among the most talked-about treatments in healthcare
10.1016/j.cardiores.2004.10.036 42 LiuY.HeY.WangQ.GuoF.HuangF.JiL.et al (2019)
US$ 29.12
US$ 26.55
US$ 29.23
US$ 20.88
US$ 28.34
US$ 20.07
US$ 29.82
US$ 29.19
